DDI-DrugBank.d756.s0 >> Dosages of concomitantly administered opioids should be reduced by approximately half, because levomepromazine amplifies the therapeutic actions and side-effects of opioids. >> 38-44,95-109,165-171
DDI-DrugBank.d756.s1 >> Combination with tramadol (Ultram) is associated with increased risk of seizures. >> 17-24,27-32
DDI-DrugBank.d756.s2 >> Additive sedative effects and confusional states may emerge if levomepromazine is given with benzodiazepines or barbiturates. >> 63-77,93-107,112-123
DDI-DrugBank.d756.s3 >> This may be avoided by using the lowest dose possible with the substances in question.
DDI-DrugBank.d756.s4 >> Exert particular caution in combining levomepromazine with other anticholinergic drugs (tricyclic antidepressants and antiparkinsonian-agents): Particularly the elderly may develop delirium, high fever, severe obstipation, even ileus and glaucoma. >> 38-52,65-85,88-112,118-140
DDI-DrugBank.d756.s5 >> Reduce both the dose of levomepromazine and the dose of the other drug. >> 24-38
DDI-DrugBank.d756.s6 >> If possible, avoid such combinations.
DDI-DrugBank.d756.s7 >> Caffeine and/or stimulantes of the ephedrine/amphetamine type may counteract the specific actions of levomepromazine. >> 0-7,35-43,45-55,101-115
DDI-DrugBank.d756.s8 >> Concomitant use of these substances should be avoided.
DDI-DrugBank.d756.s9 >> Coffee and black tea should be avoided because they decrease the absorption of levomepromazine considerably. >> 79-93
DDI-DrugBank.d756.s10 >> The same is true for antacids; >> 21-28
DDI-DrugBank.d756.s11 >> these should be given 1 to 2 hours before or after oral administration of leveomepromazine. >> 74-89
